New York, New York (PRWEB) December 12, 2013
Dozens of Tylenol lawsuits (http://www.tylenollawsuitclaims.com/ ) that allege the use of the popular over-the-counter drugs caused serious liver damage, including liver failure resulting in hospitalization, liver transplantation, and death, continue to move forward in a mulitidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania. According to documents filed in the proceeding, the Court has scheduled the Tylenol litigation’s next Status Conference for December 17, 2013. The issues to be addressed include a Motion to Compel the defense to respond fully to plaintiffs’ requests for admissions. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)
“We have heard from numerous individuals concerned about the potential association between Tylenol and liver damage, and are investigating their claims. We are pleased to see this litigation moving ahead, and look forward to more progress in the year to come,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Tylenol lawsuit reviews to victims of severe liver damage allegedly associated with the use of Tylenol-brand medications.
Tylenol Liver Damage Allegations
Tylenol lawsuits pending in the federal litigation allege that acetaminophen, the active ingredient in numerous over-the-counter medications bearing the Tylenol brand name, has the potential to cause serious liver damage even when used as directed. So far, nearly 100 lawsuits involving Tylenol and liver damage allegations have been filed in the proceeding since it was established last April.
In August, Johnson & Johnson announced it would be adding new information to the labels of Tylenol brand products that would more prominently warn of the risk of serious liver injuries associated with the drugs. According to a report from Bloomberg.com, the new red-lettered warning would first appear on Extra Strength Tylenol in October, and other products would follow. The report pointed out that each Extra Strength Tylenol tablet contains 500 milligrams of acetaminophen. By contrast, the maximum amount of acetaminophen permitted in prescription products is 325 milligrams per two tablets, Bloomberg said.*
According to data published by the U.S. Food & Drug Administration (FDA), acetaminophen was the leading cause of acute liver failure in the U.S. between 1998 and 2003. From 1990 to 1998, products containing the ingredient were blamed for 56,000 emergency room visits, 26,000 hospitalizations, and 458 deaths annually.
If you or a loved suffered an acetaminophen-induced liver injury due to the use of a Tylenol-brand product, you may be entitled to compensation for your injury-related damages. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. For a free evaluation of your claim, please call 800-511-5092.
*bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP